Details of issuance or disposal
Monthly exercise status of the Ninth Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions)
Number of shares delivered during the target month: 50,000,000 shares (50,000,000 new shares and 0 treasury shares transferred)
Exercise ratio subject to exercise restrictions: 2.9% (1,330,000 shares delivered across all series combined / 45,874,400 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the Ninth Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) |
| Number of shares to be issued or disposed of | Number of shares delivered during the target month: 50,000,000 shares (50,000,000 new shares and 0 treasury shares transferred) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 2.9% (1,330,000 shares delivered across all series combined / 45,874,400 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 44,544,400 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | The exercise prices during May 2026 were ¥151, ¥138, ¥135, ¥129, ¥127, ¥124, ¥123, ¥122 and ¥121. Details of the adjustment provisions and the floor price are not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 500,000; exercised during the target month: 13,300; unexercised as of the current date in the target month: 476,500 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing Issued on 31 March 2026 / Type Ninth Series Stock Acquisition Rights (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company stated that it was reporting the monthly exercise status of the Ninth Series Stock Acquisition Rights for May 2026.